Where does Excelsior Medical Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Excelsior Medical Corporation ranks #12,916 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Excelsior Medical Corporation hold?

Excelsior Medical Corporation holds 23 US utility patents granted between 2015 and 2024, spanning 2 technology areas.

What is Excelsior Medical Corporation's Innovation Score?

Excelsior Medical Corporation has an Innovation Score of 31.0 out of 100 (36th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Excelsior Medical Corporation's patent grant rate increasing or decreasing?

Excelsior Medical Corporation's recent grant velocity is -23% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Excelsior Medical Corporation's patents?

Excelsior Medical Corporation's patents average 17.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Excelsior Medical Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Excelsior Medical Corporation

Q: What technology areas does Excelsior Medical Corporation focus on?

Excelsior Medical Corporation's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 22 patents, ranking #335 of 3,490 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 23 granted patents across 2 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Excelsior ranks #12,916 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 2 technology areas.

#12,916
of 49,997 US assignees by volume: 36th percentile
by Innovation Score (31.0/100): 17.1
avg claims per patent: -23%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12916 · US Corporation #12,916 · 23 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 23 grants
MID-PACK #12,916/49,997
PHOTO-FINISH Elobau & KG
CPC-NARROW A61M · 2 areas
INNOV-THIN 31.0/100
CLAIMS-RICH 17.1 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -23% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Elobau GmbH & Co. KG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Excelsior’s 31.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.0 pts (35%) Velocity 4.8 pts (15%) Breadth 5.0 pts (16%) Claim depth 10.3 pts (33%)

Qualcomm Incorporated · highest

85
Excelsior Medical · this assignee

31
3D Lighting… · lowest

7

What this shows Excelsior's Innovation Score is 31.0/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Excelsior?

Each dot is one of Excelsior’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Excelsior’s own 17.1 claims/patent is ABOVE the 11.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Excelsior vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Excelsior's grants concentrate

Excelsior Medical Corporation is a focused PatentsView assignee: 2 CPC subclasses with 95.7% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2017 (6 grants) versus a trough of 1 in 2015. By volume, Excelsior sits between Elobau GmbH & Co. KG and Finelite Inc..

Excelsior's three-year grant acceleration

Excelsior Medical Corporation shows 5 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Elobau & KG

23
Enovate Medical

23
Enveric Bioscienc…

23
Ergon Asphalt & E…

23
Faltec

23
Federal-mogul Val…

23
FHE USA

23
Finelite

23
Excelsior Medical ◀

23

What this shows Excelsior holds 23 patents at rank #12,915, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Excelsior

By rank, the assignees closest to #12,915 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Excelsior's primary technology class.

Excelsior's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Excelsior Medical Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	4.3%
2016	1	4.3%
2017	6	26.1%
2018	3	13.0%
2019	2	8.7%
2020	3	13.0%
2021	2	8.7%
2022	1	4.3%
2023	1	4.3%
2024	3	13.0%

Which technologies does Excelsior Medical Corporation patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 22

A61B - DIAGNOSIS; SURGERY; Identification 3

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Excelsior Medical Corporation's patent record in context - here's where to go next.

Excelsior Medical Corporation's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 95.7% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #12,916 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Excelsior Medical Corporation against Elobau GmbH & Co. KG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.